Revolution Medicines Inc. Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $25.13 (market cap $156.97B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 3.9× Revolution Medicines Inc. Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.34% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) for 1 Days on average.
| RVMD | SMFG | |
|---|---|---|
Market Cap | $40.32B | $156.97B |
Volume | 4,855,734 | 1,237,125 |
Sector | Health | Financials |
52-Week High | $221.15 | $27.56 |
52-Week Low | $47.50 | $15.20 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $37.02B | $12.48T |
Dividend Yield | — | 2.34% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →